↓ Skip to main content

Dove Medical Press

Adherence to treatment assessed with the Adherence in Chronic Diseases Scale in patients after myocardial infarction

Overview of attention for article published in Patient preference and adherence, March 2018
Altmetric Badge

Readers on

mendeley
66 Mendeley
Title
Adherence to treatment assessed with the Adherence in Chronic Diseases Scale in patients after myocardial infarction
Published in
Patient preference and adherence, March 2018
DOI 10.2147/ppa.s150435
Pubmed ID
Authors

Agata Kosobucka, Piotr Michalski, Łukasz Pietrzykowski, Michał Kasprzak, Karolina Obońska, Tomasz Fabiszak, Mirosława Felsmann, Aldona Kubica

Abstract

A substantial subset of patients after myocardial infarction (MI) discontinue pivotal medication early after discharge. In particular, cessation of antiplatelet treatment may lead to catastrophic ischemic events. Thus, adherence to prescribed medication in patients after MI is an issue of medical and social concern. The aim of the study was to evaluate the level of adherence to treatment using a newly developed scale in patients after MI treated with percutaneous coronary intervention. A single-center, prospective, observational cohort clinical study with a 6-month follow-up was performed. Patients with physical or cognitive impairment, prisoners, soldiers, and family members and coworkers of the researchers were excluded from the study. The impact of selected sociodemographic and clinical factors on adherence was evaluated in 221 patients (63 women and 158 men) aged 30 to 91 years. The results obtained with the Adherence in Chronic Diseases Scale (ACDS) ranged from 7 to 28 points; with the average and median scored being 23.35 and 24, respectively. The ACDS score reflects the level of adherence to prescribed medication. The high ACDS scores (>26 points) were obtained in 59 (26.7%) patients, intermediate scores (21-26 points) in 110 (49.8%) and low scores (<21 points) in 52 subjects (23.5%). Acute coronary syndrome (re-ACS) occurred in 18 (8.1%) patients during the follow-up period. The high-level adherence (ACDS score >26 points) was found in 11.1% of patients with re-ACS vs 28.4% of the remaining ones (P=0.1). Lower scores (mean ± standard deviation) in re-ACS patients were found for items 2 and 3 of the ACDS: 3.11±0.68 vs 3.45±0.73 (P=0.02) and 3.28±0.89 vs 3.64±0.64 (P=0.04), respectively. Age and previous MI were found to be independent factors influencing adherence assessed with the ACDS.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 66 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 12%
Student > Master 6 9%
Student > Bachelor 6 9%
Researcher 5 8%
Other 5 8%
Other 15 23%
Unknown 21 32%
Readers by discipline Count As %
Medicine and Dentistry 14 21%
Pharmacology, Toxicology and Pharmaceutical Science 12 18%
Nursing and Health Professions 9 14%
Psychology 3 5%
Business, Management and Accounting 2 3%
Other 4 6%
Unknown 22 33%